Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
AGNAllergan plc
0.66%166.822.9%$468.68m
ZTSZoetis, Inc. Class A
1.13%125.671.9%$249.04m
TEVATeva Pharmaceutical Industries Limited Sponsored ADR
0.60%7.582.0%$152.81m
MYLMylan N.V.
1.38%21.293.2%$96.43m
TXMDTherapeuticsMD, Inc.
-1.89%3.6424.9%$8.79m
RDYDr. Reddy's Laboratories Ltd. Sponsored ADR
3.71%39.422.0%$6.63m
ABEOAbeona Therapeutics, Inc.
2.01%3.317.6%$6.53m
TAROTaro Pharmaceutical Industries Ltd.
0.32%80.536.4%$5.14m
JAGXJaguar Animal Health, Inc.
2.84%1.459.8%$2.31m
KINKindred Biosciences, Inc.
0.91%7.770.3%$1.17m
LFVNLifeVantage Corporation
0.88%13.753.3%$0.86m
CPHIChina Pharma Holdings, Inc.
1.97%0.270.1%$0.04m

Company Profile

Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS.